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Objectives: The utility of continuous theta-burst stimulation (cTBS) as index of cortical
plasticity is limited by inadequate characterization of its test–retest reliability. We thus
evaluated the reliability of cTBS aftereffects, and explored the roles of age and common
single-nucleotide polymorphisms in the brain-derived neurotrophic factor (BDNF ) and
apolipoprotein E (APOE) genes.
Methods: Twenty-eight healthy adults (age range 21–65) underwent two identical
cTBS sessions (median interval = 9.5 days) targeting the motor cortex. Intraclass
correlation coefficients (ICCs) of the log-transformed, baseline-corrected amplitude of
motor evoked potentials (1MEP) at 5–60 min post-cTBS (T5–T60) were calculated.
Adjusted effect sizes for cTBS aftereffects were then calculated by taking into account
the reliability of each cTBS measure.
Results: 1MEP at T50 was the most-reliable cTBS measure in the whole sample
(ICC = 0.53). Area under-the-curve (AUC) of 1MEPs was most reliable when calculated
over the full 60 min post-cTBS (ICC = 0.40). cTBS measures were substantially more
reliable in younger participants (< 35 years) and in those with BDNF Val66Val and APOE
ε4– genotypes.
Conclusion: cTBS aftereffects are most reliable when assessed 50 min post-cTBS, or
when cumulative 1MEP measures are calculated over 30–60 min post-cTBS. Reliability
of cTBS aftereffects is influenced by age, and BDNF and APOE polymorphisms.
Reliability coefficients are used to adjust effect-size calculations for interpretation and
planning of cTBS studies.
Keywords: transcranial magnetic stimulation, continuous theta-burst stimulation, plasticity, reliability,
BDNF, APOE
Abbreviations: %1, percent change from the baseline; 1B−A, visit-B minus visit-A; 1MEP, natural log-transformed,
baseline-corrected amplitude of motor evoked potentials; APOE, apolipoprotein E; AUC, area under-the-curve; BDNF,
brain-derived neurotrophic factor; cTBS, continuous theta-burst stimulation; FDR, false discovery rate; GABA, gamma-
aminobutyric acid; ICC, intraclass correlation coefficient; iTBS, intermittent theta-burst stimulation; LME, linear mixed-
effects regression analysis; LTD, long-term depression; LTP, long-term potentiation; NMDA, N-Methyl-D-aspartic acid; PCR,
polymerase chain reaction; Rm-ANOVA, repeated-measures analysis of variance; SNP, single-nucleotide polymorphism;
T0–Tn, over the first n minutes following cTBS; TMS, transcranial magnetic stimulation; Tn, at n minutes post-cTBS.
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INTRODUCTION
Transcranial magnetic stimulation (TMS) is a method for focal
non-invasive stimulation of the brain through electromagnetic
induction (Barker et al., 1985). Application of TMS within the
recommended guidelines (Rossi et al., 2009; Rossini et al., 2015)
is a safe means of triggering or modulating neural activity in a
given brain region or network (Pascual-Leone et al., 2011; Fox
et al., 2012; Valero-Cabré et al., 2017). A form of repetitive TMS
(rTMS) known as continuous theta-burst stimulation (cTBS)
consists of 50 Hz bursts of three TMS pulses repeated at 5 Hz
for a total of 600 pulses over 40 s (Huang et al., 2005). The
average amplitude of motor evoked potentials (MEPs) induced
by single TMS pulses is reduced by approximately 25% for up
to 50 min following cTBS of the primary motor cortex (M1)
(Wischnewski and Schutter, 2015). This neuromodulatory effect
is thought to involve mechanisms similar to long-term depression
(LTD) (Pascual-Leone et al., 1994; Huang et al., 2005; Hallett,
2007). Therefore, the pattern of cTBS-induced changes in MEPs
provides a neurophysiologic index of the mechanism of cortical
plasticity (Pascual-Leone et al., 2005, 2011; Oberman et al., 2010,
2012, 2014, 2016; Suppa et al., 2016).
The neuromodulatory effect of cTBS applied to M1 or
other brain regions has been investigated for its potential as a
neurophysiological biomarker and a therapeutic intervention in
several neurological and psychiatric disorders (Koch et al., 2009,
2012; Eberle et al., 2010; McClintock et al., 2011; Cazzoli et al.,
2012; Oberman et al., 2012, 2014; Di Lazzaro et al., 2013, 2016;
Mori et al., 2013; Cantone et al., 2014; Chuang et al., 2014; Forogh
et al., 2014; Li et al., 2014; Suppa et al., 2014; Carrette et al.,
2016). Despite its growing popularity, however, cTBS responses
show large inter-individual (Hamada et al., 2013; Goldsworthy
et al., 2014; López-Alonso et al., 2014; Vallence et al., 2015; Guerra
et al., 2017; Heidegger et al., 2017; Hordacre et al., 2017; Jannati
et al., 2017) and intra-individual variability (Vernet et al., 2014;
Vallence et al., 2015) that can limit the utility of cTBS for assessing
brain plasticity in clinical populations.
Only two published studies have assessed the reproducibility
of cTBS aftereffects (Vernet et al., 2014; Vallence et al.,
2015). The first (Vernet et al., 2014) used a relatively
small sample size (n = 10) and did not report reliability
coefficients of cTBS aftereffects, which can be compared with
the reliability coefficients of other TMS measures (Carroll
et al., 2001; Kimiskidis et al., 2004; Christie et al., 2007;
Livingston and Ingersoll, 2008; Bastani and Jaberzadeh, 2012;
Ngomo et al., 2012; Hinder et al., 2014; Liu and Au-Yeung,
2014; Sankarasubramanian et al., 2015; Schambra et al., 2015;
Hermsen et al., 2016; Fried et al., 2017). The second study
(Vallence et al., 2015) used an input–output curve approach that
allowed assessment of cTBS aftereffects elicited over a range
of stimulation intensities, but at the cost of fewer time-points.
Specifically, assessments were only performed at 0, 15, and 30 min
post-cTBS. This excluded the earliest time points, i.e., 5 and
10 min post-cTBS, which typically exhibit the maximal cTBS
effects (Wischnewski and Schutter, 2015) and later time-points,
i.e., 40–60 min post-cTBS, which capture the longer-lasting TBS
effects and have been found to be useful in differentiating clinical
populations such as individuals with Alzheimer’s disease (Freitas
et al., 2011), autism spectrum disorder (Oberman et al., 2012),
diabetes (Fried et al., 2016), and schizophrenia (McClintock et al.,
2011) from healthy individuals. For comparison, at least three
studies have assessed the reliability of intermittent theta-burst
stimulation (iTBS) aftereffects (Hinder et al., 2014; Fried et al.,
2017; Schilberg et al., 2017).
Full characterization of the test–retest reliability of cTBS
aftereffects is essential to properly interpret results and plan
for future studies. We thus aimed to address this need
by systematically assessing the test–retest reliability of cTBS
aftereffects in 5- or 10-min intervals for 60 min post-cTBS in
a sizeable sample of healthy adults. We also calculated adjusted
effect sizes for cTBS aftereffects by taking into account the
reliability (or lack thereof) of each cTBS measure (Friedman,
1968; Wright, 2014; Fried et al., 2017). In addition, we
explored the effects of age group on the reproducibility of
cTBS aftereffects, as well as of single-nucleotide polymorphisms
(SNPs) in brain-derived neurotrophic factor (BDNF) and
apolipoprotein E (APOE) genes, which have been found to
influence neuroplasticity (White et al., 2001; Cheeran et al.,
2008; Nichol et al., 2009; Antal et al., 2010; Peña-Gomez et al.,
2012; Lee et al., 2013; Chang et al., 2014; Di Lazzaro et al.,
2015; Jannati et al., 2017). Our results can improve the utility
of cTBS as a neurophysiologic index of cortical plasticity in
neurological and psychiatric disorders, help elucidate the sources
of intra-individual variability in cTBS responses, and ensure




Twenty-eight healthy adults (25 males, age range: 21–65)
participated in the study, which was approved by the local
Institutional Review Board in accordance with the Declaration
of Helsinki. All participants provided written informed consent
prior to enrollment and received monetary compensation
upon completion. None of the participants had any TMS
contraindication (Rossi et al., 2009), and all had normal
physical and neurological examinations. Individual and group-
level demographics are presented in Tables 1 and 2, respectively.
Neuropsychological Testing
Mini-Mental State Examination (Folstein et al., 1975; Crum
et al., 1993) and the Abbreviated Battery of Stanford–Binet
IV intelligence scale (Thorndike et al., 1986), including
Verbal Knowledge and Non-Verbal Fluid Reasoning
subscores, were completed.
Genetic Analyses
Saliva samples from 22 participants were assessed for BDNF
Val66Met polymorphism and the presence of APOE ε4 allele,
as reported previously (Jannati et al., 2017). Aliquot (700 µL)
extraction of genomic DNA was performed on saliva samples
collected using the Oragene Discover OGR-250 Kit (DNA
Frontiers in Neuroscience | www.frontiersin.org 2 May 2019 | Volume 13 | Article 447
fnins-13-00447 May 16, 2019 Time: 14:41 # 3


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Frontiers in Neuroscience | www.frontiersin.org 3 May 2019 | Volume 13 | Article 447
fnins-13-00447 May 16, 2019 Time: 14:41 # 4
Jannati et al. cTBS Reliability in Healthy Adults
TABLE 2 | Participants’ demographics, single-nucleotide polymorphisms, neuropsychological results, and neurophysiological measures for the total sample and for the
age and genetic subgroups.
All Age < 35 Age ≥ 45 BDNF Met− BDNF Met+ APOE ε4− APOE ε4+
(N = 28) (n = 16) (n = 12) p (n = 14)† (n = 8)† p (n = 12)† (n = 10)† p
Age (year, mean ± SD) 36.8 ± 14.5 25.3 ± 4.3 52.1 ± 6.5 N/ A 36.6 ± 14.4 37.8 ± 15.4 0.86 33.8 ± 12.6 40.8 ± 16.1 0.27
Sex (M : F) 25 : 3 15 : 1 10 : 2 0.56 13 : 1 8 : 0 1.00 11 : 1 10 : 0 1
Race (White : non-White) 16 : 12 9 : 7 7 : 5 1.00 10 : 4 4 : 4 0.39 9 : 3 5 : 5 0.38
Ethnicity (Hispanic : non-Hispanic) 6 : 22 6 : 10 0 : 12 0.02 9 : 5 7 : 1 0.35 7 : 5 9 : 1 0.16
Education (year, mean ± SD)∗ 17.0 ± 2.3 17.4 ± 1.9 16.4 ± 2.8 – 17.3 ± 2.4 17.8 ± 2.1 0.69 17.3 ± 1.6 17.7 ± 2.8 –
BDNF (Met− : Met+)† 14 : 8 8 : 5 6 : 3 – 14 : 0 0 : 8 N/A 8 : 4 6 : 4 1.00
APOE (ε4− : ε4+)† 12 : 10 8 : 5 4 : 5 – 8 : 6 4 : 4 1.00 12 : 0 0 : 10 N/ A
Handedness (Right: Left ) 27 : 1 15 : 1 12 : 0 1.00 14 : 0 7 : 1 0.36 12 : 0 9 : 1 0.46
MMSE score (mean ± SD) 29.8 ± 0.5 29.7 ± 0.6 29.9 ± 0.3 0.24 29.8 ± 0.4 29.6 ± 0.7 0.52 29.7 ± 0.7 29.8 ± 0.4 0.58
IQ (mean ± SD) 108.9 ± 12.3 110.1 ± 10.6 107.2 ± 14.7 0.55 112.4 ± 12.0 107.9 ± 13.1 0.42 112.5 ± 13.2 108.7 ± 11.5 0.49
Verbal KN score 11.9 ± 2.9 11.8 ± 3.0 12.2 ± 2.9 0.71 13.1 ± 2.9 11.3 ± 2.9 0.16 12.6 ± 2.9 12.3 ± 3.2 0.83
Non-verbal FR score 11.0 ± 2.0 11.6 ± 1.6 10.3 ± 2.4 0.08 11.0 ± 2.0 11.4 ± 2.4 0.70 11.6 ± 2.0 10.6 ± 2.3 0.30
RMT (% MSO, mean ± SD)
Visit A 35.3 ± 7.6 35.4 ± 8.7 35.3 ± 6.4 0.97 32.4 ± 5.5 38.1 ± 9.7 0.09 31.2 ± 6.0 37.9 ± 8.2 0.054
Visit B 35.9 ± 7.7 35.9 ± 8.2 35.9 ± 7.4 0.99 33.6 ± 5.8 37.4 ± 10.1 0.27 32.4 ± 6.4 38.0 ± 8.3 0.09
AMT (% MSO, mean ± SD)
Visit A 25.9 ± 5.2 26.6 ± 5.9 25.0 ± 4.0 0.44 24.3 ± 3.7 27.3 ± 6.2 0.18 24.6 ± 4.8 26.3 ± 5.1 0.42
Visit B 25.7 ± 4.6 25.9 ± 5.0 25.4 ± 4.3 0.78 24.3 ± 3.2 26.8 ± 5.9 0.21 24.3 ± 4.2 26.3 ± 4.6 0.29
Baseline MEP amplitude
(mV, mean ± SD)
Visit A 1.3 ± 1.5 1.1 ± 1.1 1.5 ± 1.9 0.42 1.2 ± 1.2 0.8 ± 0.5 0.45 1.1 ± 1.3 1.0 ± 0.5 0.75
Visit B 1.1 ± 1.0 1.2 ± 1.0 1.1 ± 1.0 0.82 1.4 ± 1.0 0.7 ± 0.4 0.08 1.2 ± 1.1 0.9 ± 0.5 0.43
Intervisit interval (days) (mean ± SD) 12.8 ± 7.4 11.4 ± 7.0 14.8 ± 7.8 0.24 12.1 ± 7.3 12.6 ± 5.6 0.86 12.1 ± 7.9 12.5 ± 5.0 0.89
|1B−A | Start Time
(min, mean ± SD)
42.5 ± 62.2 30.0 ± 62.9 59.2 ± 59.7 0.23 55.8 ± 74.6 14.8 ± 19.0 0.15 47.7 ± 72.6 32.7 ± 51.9 0.59
Comparisons of proportions were conducted with Fisher’s exact test. Education and single-nucleotide polymorphisms were not statistically compared between the
subgroups because the data were not available for the total sample. The p-values were not adjusted for multiple comparisons. The p-value < 0.05 is highlighted in
bold font. |1B-A |, absolute inter-visit difference; AMT, active motor threshold; APOE, apolipoprotein E; APOE ε4+, ε2/ε4 or ε3/ε4 genotype; APOE ε4–, ε2/ε3 or ε3/ε3;
BDNF, brain-derived neurotrophic factor; BDNF Met–, Val66Val; BDNF Met+, Val66 Met; FR, fluid reasoning; IQ, intelligence quotient; KN, knowledge; MEP, motor evoked
potential; Met, metionine; MMSE, Mini-Mental State Examination; MSO, maximum stimulator output; RMT, resting motor threshold; SD, standard deviation; Val, valine.
∗Education data were available for 26 participants. †BDNF and APOE results were available for 22 participants.
Genotek Inc., Ottawa, ON, Canada). DNA was extracted from
samples using standard methodology and the prepIT L2P reagent
(DNA Genotek Inc., 2015). The rs6265 SNP of the BDNF gene,
and the rs429358 and the rs7412 SNPs of the APOE gene were
analyzed using a TaqMan single-tube genotyping assay, which
uses polymerase chain reaction (PCR) amplification and a pair of
fluorescent dye detectors that target the SNP. During PCR, the
polymerase released the fluorescent probe into solution where
it was detected using endpoint analysis in an 7900HT Real-
Time instrument from Applied Biosystems, Inc. (Foster City,
CA, United States).
Transcranial Magnetic Stimulation
Two identical TMS visits (7–33 days apart; median
interval = 9.5 days) were conducted. The starting times of the two
visits were 0–254 min apart (interquartile range = 1–103 min;
median = 12 min). The inter-visit intervals and starting-time
differences for individual subjects are presented in Table 1.
All TMS procedures followed the recommended guidelines
endorsed by the International Federation of Clinical
Neurophysiology (Rossi et al., 2009; Rossini et al., 2015).
Participants were seated in a comfortable chair with the right
arm and hand in a natural pronated ∼90◦ angle on a pillow in
front of them. They were instructed to keep their right hand as
still and relaxed as possible throughout the experiment. They
were also monitored for drowsiness and were asked to keep
their eyes open during the TMS application. Single TMS pulses
and cTBS were applied to the left primary motor cortex (M1) at
120% of individual resting motor threshold (RMT) and 80% of
active motor threshold (AMT), respectively, as biphasic pulses
with an antero-posterior–postero-anterior (AP-PA) induced
current direction using a MagPro X100 stimulator and a MC-B70
Butterfly Coil (outer diameter: 97 mm; MagPro, MagVenture
A/S, Farum, Denmark). The coil was held tangentially to the
participant’s head surface, with the handle pointing occipitally
and positioned at 45◦ relative to the mid-sagittal axis of the
participant’s head. The optimal spot for the maximal responses
of the right first dorsal interosseous (FDI) muscle (“motor
hotspot”) was localized. A Polaris infrared-optical tracking
system (Northern Digital Inc., Waterloo, ON, Canada) and
a Brainsight TMS neuronavigation system (Rogue Research
Inc., Montreal, QC, Canada) with a brain MRI template
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(for 21 participants) or the participant’s brain MRI (for the
remaining 7 participants) was used to ensure consistent targeting
throughout the experiment.
Surface electromyogram (EMG) was recorded from the
right FDI with a PowerLab 4/25 data-acquisition device and
LabChart 8 software (AD Instruments, Colorado Springs, CO,
United States). Electrodes were placed over the FDI belly
(negative) and the first interphalangeal joint of the second finger
(positive). The ground electrode was placed over the ipsilateral
ulnar styloid process. The TMS system delivered triggered pulses
that synchronized the TMS and EMG systems. EMG signal was
digitized at 1 kHz for 500 ms following each stimulus trigger and
100 ms pre-trigger, amplified with a range of±10 mV (band-pass
filter 0.3–1000 Hz).
Each TMS session began by localizing the motor hotspot for
FDI and assessment of the RMT, defined as the lowest intensity
of stimulation that elicited MEPs ≥ 50 µV in at least five of ten
pulses in the relaxed right FDI. To assess pre-cTBS cortico-motor
reactivity, three blocks of 30 single TMS pulses were applied
to M1, with a 5–10 min inter-block interval and at a random
4–6 s inter-pulse interval. In each block, individual MEPs > 2.5
SD from the mean were excluded. Baseline MEP amplitude was
calculated as the average of the peak-to-peak amplitude of MEPs
in the three blocks. The AMT was then assessed as the lowest
intensity that elicited MEPs≥ 200 µV in at least five of ten pulses
with the FDI slightly contracted. After a 5-min break, during
which participants were instructed to maintain hand relaxation
to control the effects of voluntary hand movements on cTBS
responses (Iezzi et al., 2008), cTBS was applied as 200 bursts of
three pulses at 50 Hz, repeated at 200-ms intervals for 40 s (for a
total of 600 pulses). Cortico-motor reactivity was reassessed at 5,
10, 15, 20, 30, 40, 50, and 60 min post-cTBS (T5–T60).
Statistical Analyses
Stata software version 13.1 (StataCorp, College Station, TX,
United States) and MATLAB and Statistics and Machine
Learning Toolbox R2016b (The MathWorks, Natick, MA,
United States) were used for data analysis. Data from each
TMS visit included: (a) RMT and AMT, expressed as percentage
of maximum stimulator output; (b) baseline MEP amplitude,
calculated as the average of baseline MEP amplitude in 3 blocks
of 30 single TMS pulses; and (c) percent change in the average
amplitude of 30 MEPs at T5–T60 relative to baseline (%1) for
each participant.
The Shapiro–Wilk test found significant deviations in MEP
values from normal distribution; thus, natural log-transformed,
baseline-corrected MEP amplitude at each post-cTBS time point
(1MEP) was averaged over all participants separately for each
visit. The following measures were also calculated: absolute MEP
modulation at T5–T60 (|1MEP|), maximum suppression and
maximum modulation of MEPs during 60 min post-cTBS, area
under-the-curve (AUC) and the absolute AUC value (|AUC|)
of 1MEPs over T0–T10, . . . , and T0–T60 intervals. Cumulative
AUC and |AUC| measures up to each time-point were calculated
as the summed products of the average 1MEP and the average
|1MEP|, respectively, across each two consecutive time-points
and the time in minutes between them.
Grand-average values for all cTBS measures were calculated
separately for both visits and were compared against zero using
one-sample t-tests. Visit-B minus visit-A difference (1B−A) and
|1B−A| were calculated for each neurophysiological measure
(Table 3). All analyses were two-tailed, and the α level was set to
0.05. When explicitly noted, false discovery rate (FDR) was used
to adjust p-values for multiple testing (Benjamini and Hochberg,
1995; Benjamini and Yekutieli, 2001).
1MEPs at T10 and T40 were previously found to be the
best predictors of inter-individual variability in cTBS aftereffects
in visit-A (Jannati et al., 2017). Thus, to assess the effect of
potential covariates on the intra-individual variability of cTBS
aftereffects at T10 and T40, we conducted linear mixed-effects
(LME) regression analyses with 1MEPs at T10 or T40 as
dependent variable, Visit (visit-A vs. visit-B) as a within-subject
factor, and potential covariates including RMT, AMT, baseline
MEP amplitude, number of days between the two visits (Inter-
visit Interval), and the absolute inter-visit difference in starting
time (in minutes) (Time Difference) as between-subject factors.
Based on previous studies that found in many situations a
regression model is likely to be reliable when the number of
candidate predictors is smaller than one-tenth of the number
of subjects (Harrell, 2015) (p. 72), up to three between-subjects
predictors were considered for simultaneous inclusion in any
regression model.
To assess test–retest reliability, intraclass correlation
coefficients (ICCs) (Portney and Watkins, 2009) were calculated
in the form of absolute agreement between the two visits for
all neurophysiological measures. ICCs were calculated using a
two-way mixed-effects model, with fixed column (C) effects and
random row (R) effects (McGraw and Wong, 1996):
ICC(A, 1) =
MSR −MSE
MSR + (k− 1)MSE + kn (MSC −MSE)
where ICC(A,1) represents the degree of absolute agreement
of measurements made under the two fixed levels of the
column factor. k = the number of raters/measurements per
subject; MSR = mean square for rows (representing the
individual subjects); MSE = mean square error; MSC = mean
square for columns (representing the two visits); n = the
number of subjects.
Using this formula, ICC = 1 indicates maximum reliability
and ICC ≤ 0 indicates no reliability [in the case that the within-
group variance is equal to or higher than the between-groups
variance (Kenny et al., 2002)]. ICC values were interpreted as
follows (Portney and Watkins, 2009): (i) ICC < 0.25: very low
to no reliability; (ii) 0.25 ≤ ICC < 0.50: low reliability; (iii)
0.50 ≤ ICC < 0.75: moderate reliability; and (iv) ICC ≥ 0.75:
high reliability. ICC values were statistically compared using two-
way mixed-effects F statistics (McGraw and Wong, 1996, Table 8).
The effects on the ICCs of covariates that had a significant
effect on 1MEPs were assessed by including the covariate in the
corresponding mixed-effects regression model and re-calculating
the residual intraclass correlation.
Lack of reliability of a measure of interest attenuates the
observed effect size compared to the population parameter
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TABLE 3 | Neurophysiological measures (mean ± SD) and their test-retest reliability for the whole sample (N = 28).
Reproducibility-adjusted
effect sizes
Visit A Visit B 1B−A |1B−A | ICC p
Cohen’s Cohen’s Cohen’s
d = 0.2 d = 0.5 d = 0.8
Motor threshold (% MSO)
RMT 35.3 ± 7.6 35.9 ± 7.7 0.6 ± 2.2 1.8 ± 1.4 0.96 <0.001 0.20 0.50 0.79
AMT 25.9 ± 5.2 25.7 ± 4.6 −0.2 ± 1.8 1.5 ± 1.1 0.93 <0.001 0.20 0.49 0.78
Baseline MEP amplitude (mV) 1.3 ± 1.5 1.1 ± 1.0 −0.2 ± 1.0 0.6 ± 0.8 0.70 <0.001 0.18 0.46 0.72
Post-cTBS 1MEP
T5 −0.05 ± 0.3 −0.07 ± 0.4 −0.02 ± 0.5 0.41 ± 0.3 0.16 0.213 0.13 0.31 0.48
T10 −0.02 ± 0.4 0.08 ± 0.4 0.11 ± 0.5 0.42 ± 0.3 0.11 0.289 0.12 0.28 0.44
T15 0.09 ± 0.3 0.00 ± 0.3 −0.09 ± 0.5 0.40 ± 0.3 −0.16 0.791 − − −
T20 0.10 ± 0.3 0.03 ± 0.4 −0.07 ± 0.5 0.39 ± 0.3 0.20 0.157 0.13 0.33 0.51
T30 0.07 ± 0.4 −0.02 ± 0.5 −0.09 ± 0.5 0.36 ± 0.4 0.37 0.024 0.16 0.39 0.61
T40 0.07 ± 0.4 −0.06 ± 0.5 −0.14 ± 0.5 0.40 ± 0.3 0.26 0.076 0.14 0.35 0.55
T50 0.08 ± 0.4 0.07 ± 0.5 −0.01 ± 0.5 0.37 ± 0.3 0.53 0.002 0.17 0.42 0.67
T60 −0.04 ± 0.5 0.03 ± 0.6 0.08 ± 0.8 0.61 ± 0.5 −0.08 0.653 − − −
Maximum suppression −0.50 ± 0.5 −0.53 ± 0.5 −0.03 ± 0.6 0.45 ± 0.3 0.38 0.024 0.16 0.39 0.61
Post-cTBS |1MEP|
T5 0.29 ± 0.2 0.33 ± 0.2 0.04 ± 0.3 0.29 ± 0.2 −0.27 0.912 − − −
T10 0.31 ± 0.2 0.28 ± 0.2 −0.03 ± 0.4 0.27 ± 0.2 −0.18 0.815 − − −
T15 0.26 ± 0.2 0.26 ± 0.2 0.00 ± 0.3 0.21 ± 0.1 0.11 0.297 0.11 0.28 0.44
T20 0.29 ± 0.2 0.33 ± 0.3 0.03 ± 0.3 0.22 ± 0.1 0.29 0.068 0.15 0.36 0.57
T30 0.33 ± 0.3 0.37 ± 0.3 0.03 ± 0.3 0.20 ± 0.2 0.50 0.003 0.17 0.42 0.66
T40 0.32 ± 0.2 0.32 ± 0.3 0.00 ± 0.4 0.24 ± 0.3 0.17 0.190 0.13 0.32 0.49
T50 0.33 ± 0.3 0.35 ± 0.3 0.02 ± 0.4 0.29 ± 0.2 0.34 0.037 0.15 0.38 0.59
T60 0.37 ± 0.3 0.44 ± 0.4 0.07 ± 0.5 0.35 ± 0.3 −0.03 0.567 − − −
Maximum modulation (|1MEP|) 0.76 ± 0.4 0.86 ± 0.4 0.10 ± 0.4 0.35 ± 0.3 0.31 0.045 0.15 0.37 0.58
AUC of 1MEPs
T0–T10 −0.33 ± 2.3 −0.15 ± 2.4 0.18 ± 3.1 2.55 ± 1.6 0.13 0.257 0.12 0.29 0.46
T0–T15 −0.16 ± 3.6 0.05 ± 3.4 0.21 ± 4.6 3.94 ± 2.2 0.15 0.228 0.12 0.31 0.48
T0–T20 0.31 ± 4.7 0.10 ± 4.6 −0.20 ± 6.0 5.14 ± 2.9 0.18 0.183 0.13 0.32 0.50
T0–T30 1.13 ± 7.2 0.15 ± 8.0 −0.99 ± 9.2 7.41 ± 5.4 0.27 0.078 0.14 0.36 0.56
T0–T40 1.85 ± 10.2 −0.26 ± 11.9 −2.12 ± 13.2 10.28 ± 8.3 0.29 0.061 0.15 0.36 0.57
T0–T50 2.60 ± 13.3 −0.25 ± 15.4 −2.85 ± 16.2 12.70 ± 10.2 0.36 0.026 0.16 0.38 0.60
T0–T60 2.77 ± 16.5 0.26 ± 19.1 −2.51 ± 19.7 15.94 ± 11.5 0.40 0.018 0.16 0.39 0.62
|AUC| of 1MEP
T0–T10 2.22 ± 1.2 2.36 ± 1.4 0.14 ± 2.1 1.74 ± 1.2 −0.35 0.961 − − −
T0–T15 3.63 ± 1.7 3.70 ± 2.1 0.07 ± 3.1 2.51 ± 1.8 −0.32 0.946 − − −
T0–T20 5.02 ± 2.1 5.16 ± 2.7 0.14 ± 3.5 2.72 ± 2.2 −0.08 0.647 − − −
T0–T30 8.15 ± 3.3 8.64 ± 4.1 0.48 ± 4.4 3.48 ± 2.7 0.31 0.053 0.15 0.37 0.58
T0–T40 11.42 ± 5.0 12.05 ± 6.2 0.64 ± 6.2 4.66 ± 4.0 0.39 0.018 0.16 0.39 0.61
T0–T50 14.66 ± 6.7 15.37 ± 8.3 0.71 ± 7.9 5.96 ± 5.2 0.45 0.008 0.16 0.41 0.64
T0–T60 18.17 ± 8.1 19.33 ± 10.6 1.16 ± 9.9 6.00 ± 0.1 0.46 0.007 0.16 0.41 0.64
AUC and |AUC| of 1MEPs were calculated as the summed products of the average 1MEP and the average |1MEP|, respectively, across two consecutive time-points
and the time in minutes between them. The ICC values with p < 0.05 are highlighted in bold font. Abbreviations: 1B-A, Visit B minus Visit A; |1B-A |, absolute inter-
visit difference; AMT, active motor threshold; AUC, area under-the-curve; 1MEP, natural log-transformed, baseline-corrected MEP amplitude; ICC, intraclass correlation
coefficient; MEP, motor evoked potential; MSO, maximum stimulator output; RMT, resting motor threshold; T0–Tn, over the first n minutes following cTBS.
(Hunter and Schmidt, 1994). Following previously applied
methodology (Friedman, 1968; Wright, 2014; Fried et al., 2017),
we assessed how test–retest reliability (or lack thereof) of
TMS measures would attenuate small, medium, and large effect
sizes, i.e., Cohen’s d values of 0.2, 0.5, and 0.8 (Cohen, 1992),
respectively, which assume perfect reproducibility. First, each
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Finally, the adjusted r is converted back to an adjusted d





Though unintended, the age of our participants conformed to a
bimodal distribution. Thus, to explore the impact of age on our
reliability measures, the total sample was subdivided into two
distinct age groups with a 10-year gap and a ∼27-year difference
in mean age: a Younger group with age < 35 (n = 16; range: 21–34;
mean± SD, 25.3± 4.3) and an Older group with age≥ 45 (n = 12;
range: 45–65; mean ± SD, 52.1 ± 6.5). To explore the effect of
age on the test–retest reliability of cTBS aftereffects: (i) the ICC
values of TMS measures were calculated separately for the two
age groups; (ii) separate repeated-measures analyses of variance
(Rm-ANOVAs) were conducted with 1MEP at T10 or T40 as
dependent variable, Age Group as a between-subjects factor, Visit
as a within-subject factor, and Age Group × Visit interaction.
Because the proportion of Hispanic participants was significantly
higher in the Younger group than in the Older group, we assessed
the effect of Ethnicity as a categorical covariate in these Rm-
ANOVAs. We also re-calculated all the ICCs for the Younger
group while controlling for Ethnicity.
To explore the roles of BDNF and APOE SNPs in the
reliability of TMS measures, we calculated the ICC values of
neurophysiological measures over the two visits separately for
participants with BDNF Val/Val (Met–; n = 14) and Val/Met
(Met+; n = 8) genotypes as well as for those with APOE
ε2/ε3 or ε3/ε3 (ε4–; n = 12) and APOE ε2/ε4 or ε3/ε4 (ε4+;
n = 10) genotypes.
Because BDNF was previously found to influence the cTBS
aftereffect at T10 (Jannati et al., 2017), we assessed the cTBS
aftereffects separately for BDNF Met– and Met+ participants in
each visit and conducted a Rm-ANOVA with 1MEP at T10 as
dependent variable, BDNF Status (Met– vs. Met+) as a between-
subjects factor, Visit (visit-A vs. visit-B) as a within-subject factor,
and BDNF Status × Visit interaction. Further, we assessed the
effect of BDNF Status as a covariate in the LME regression
analyses at T10.
RESULTS
Demographics, neuropsychological measures, inter-visit interval,
starting times of the two visits, and inter-visit differences in
starting time for individual participants are presented in Table 1.
Statistical comparisons of these measures between the two age
groups are presented in Table 2.
Genetic Analyses
Available BDNF and APOE results and comparisons of
all available measures between BDNF/APOE subgroups are
presented in Tables 1 and 2, respectively.
Among 22 participants with available DNA results, the
frequencies of BDNF Val/Val and Val/Met genotypes were 0.64
and 0.36, respectively, while the frequencies of APOE ε2/ε3,
ε3/ε3, and ε3/ε4 genotypes were 0.14, 0.41, and 0.46, respectively.
BDNF and APOE subgroups were comparable in all available
measures (Table 2).
Baseline Neurophysiological Measures
The RMT, AMT, and baseline MEP amplitude in each visit
and their inter-visit differences are summarized in Tables 2 and
3, respectively.
There were no significant differences in any of the baseline
neurophysiological measures in either visit between age or
genetic subgroups (Table 2). There was also no significant
difference between the two visits in any of the baseline
neurophysiological measures for the whole sample (p’s > 0.14),
for each age group (p’s > 0.17), or for each BDNF (p’s > 0.08) or
APOE (p’s > 0.28) subgroup.
The LME regression analyses of 1MEP at T10 found a
significant, negative effect of Time Difference in all models
(p’s < 0.025), but no significant effect of any of the baseline
neurophysiological measures or Visit (p’s > 0.21). LME regression
analyses of 1MEP at no other time point found a significant effect
of Time Difference (p’s > 0.41).
cTBS-Induced Plasticity Results
Grand-average 1MEPs in visits A and B are shown in
Figure 1. 1MEP and |1MEP| values, maximum suppression
and maximum modulation as well as their inter-visit differences
FIGURE 1 | Grand-average 1MEPs recorded from the right FDI muscle at 5
to 60 min following cTBS of the left primary motor cortex in two identical visits.
The 1MEPs did not significantly differ from zero at any post-cTBS time point
in either visit (p’s > 0.11). Error bars represent standard error of the mean.
cTBS, continuous theta-burst stimulation; 1MEP, natural log-transformed,
baseline-corrected amplitudes of the motor evoked potential; FDI, first
dorsal interosseous.
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FIGURE 2 | Average 1MEPs recorded from the right FDI muscle at 5 to 60 min following cTBS of the left primary motor cortex in two identical visits in the Younger
(A) and Older (B) groups. The 1MEPs did not significantly differ from zero at any time point in either visit in the Younger group (p’s > 0.06). ∗The 1MEPs in the Older
group were significantly greater than zero at T20 in visit-A (PFDR = 0.029), but not at any other time point in either visit (p’s > 0.18). Error bars represent standard
error of the mean. cTBS, continuous theta-burst stimulation; 1MEP, natural log-transformed, baseline-corrected amplitudes of the motor evoked potential; FDI, first
dorsal interosseous; FDR, false discovery rate.
are summarized in Table 3. Grand-average 1MEPs did not
significantly differ from zero at any time point in either visit
(p’s > 0.11). There was also no significant difference in grand-
average 1MEP or |1MEP| between the two visits at any time
point (p’s > 0.16).
The 1MEPs in the Older group were significantly greater than
zero at T20 in visit-A (PFDR = 0.029), but not at any other time
point in either visit (p’s > 0.18). The 1MEPs in the Younger
group did not significantly differ from zero at any time point in
either visit (p’s > 0.06). The 1MEPs in the BDNF Met– group
were significantly less than zero at T10 in visit-A (PFDR = 0.042),
but not at any other time point in either visit (p’s > 0.14). The
1MEPs in the BDNF Met+ group were not significantly different
from zero at any time point in either visit (PFDR’s > 0.05). cTBS
aftereffects in both visits for the two age subgroups and the two
BDNF subgroups are presented in Figures 2 and 4 respectively.
The Rm-ANOVA on the 1MEP at T10 found a significant
effect of BDNF status, F(1, 20) = 8.28, p = 0.009, η2p = 0.29,
but no significant effects of Visit or BDNF × Visit interaction
(p’s > 0.10). BDNF Met-carrier status had a significant positive
effect in all LME regression analyses of 1MEP at T10 (B̂’s > 0.28,
p’s < 0.027). There was no other significant effect in any of the
LME models (p’s > 0.08).
To control for potential effects of gender, race/ethnicity, and
handedness on cTBS-induced plasticity measures, we calculated
1MEP’s at T5–T60 in a subgroup of White, non-Hispanic, and
right-handed males (n = 11, Table 1). In this smaller, but more-
homogenous subsample, 1MEPs did not significantly differ from
zero at any time point in either visit (p’s > 0.23).
Test–Retest Reliability of TMS Measures
Measures of inter-visit variability and test–retest reliability for
RMT, AMT, baseline MEP amplitude and cTBS measures, as well
as reliability-adjusted effect sizes for each TMS measure in the
whole group are presented in Table 3.
The ICCs of baseline neurophysiological measures was not
significantly different between the two age groups (p’s > 0.19;
Figure 3). In contrast, 1MEPs in the Younger group were
significantly more reliable than in the Older group at T10 and
T60 (PFDR’s < 0.015), but not at other individual time points
(PFDR’s > 0.058). Similarly, |AUC| measures were significantly
more reliable in the Younger group than in the Older group over
T0–T20 and beyond (PFDR’s < 0.001; Figure 3). The reliability of
other cumulative 1MEP measures was not significantly different
between the two age groups (p’s > 0.058). After adjusting for
Ethnicity, none of the ICCs in the Younger group crossed our
pre-defined boundaries for interpretation of ICC values (see
“Materials and Methods” section).
To control for potential effects of gender, race/ethnicity, and
handedness on the test–retest reliability of cTBS aftereffects,
we calculated the ICC values of baseline neurophysiological
measures and 1MEP’s at T5–T60 among White, non-Hispanic,
and right-handed males (n = 11, Table 1). The ICC values of RMT,
AMT, and baseline MEP amplitude in this subgroup were 0.86
(p < 0.001), 0.96 (p < 0.001), and 0.75 (p = 0.003), respectively.
The ICC values of 1MEP at T5, T10, T15, T20, T30, T40, T50,
and T60 in this subgroup were 0.54 (p = 0.031), –0.09 (p = 0.602),
0.18 (p = 0.297), 0.71 (p = 0.005), 0.86 (p < 0.001), 0.67
(p = 0.008), 0.79 (p = 0.001), and 0.17 (p = 0.309), respectively.
The ICCs of baseline neurophysiological measures were
not significantly different between either the BDNF or
the APOE subgroups (p’s > 0.16; Figure 5). In contrast,
1MEPs were significantly more reliable in BDNF Met–
participants than in BDNF Met+ participants at T20–T40
(PFDR’s < 0.023), but not at other time points (p’s > 0.24).
Maximum suppression, maximum modulation, and AUC of
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FIGURE 3 | Test–retest reliability of baseline neurophysiological measures and post-cTBS 1MEP measures separately in the Younger (age < 35, n = 16) and Older
(age ≥ 45, n = 12) groups. |AUC| of 1MEPs were calculated as the summed products of the average |1MEP| across each two consecutive time-points and the time
in minutes between them over T0–T10, T0–15, . . . , T0–T60 intervals (marked by their end time point on the abscissa). The ICCs of the RMT, AMT, and baseline MEP
amplitude were not significantly different between the two age groups (p’s > 0.19). The |AUC| of 1MEPs were significantly more reliable in the Younger group than in
the Older group over T0–T15 and beyond (PFDR’s < 0.001). The reliability of other cumulative 1MEP measures was not significantly different between the two age
groups (p’s > 0.058). AUC, area under-the-curve; cTBS, continuous theta-burst stimulation; FDR, false discovery rate; 1MEP, natural log-transformed,
baseline-corrected MEP amplitude; ICC, intraclass correlation coefficient; MEP, motor evoked potential; T0–Tn, over the first n minutes post-cTBS.
1MEPs over T0–T30 and beyond were significantly more reliable
in BDNF Met– participants than in BDNF Met+ participants
(PFDR’s < 0.032; Figure 5). The reliability of other cumulative
1MEP measures was not significantly different between the two
BDNF subgroups (PFDR > 0.21).
1MEPs were significantly more reliable in APOE ε4–
participants than in APOE ε4+ participants at T5 and T20–T40
(PFDR’s < 0.024), but not at other time points (PFDR’s > 0.07).
All AUC measures were significantly more reliable in APOE ε4–
participants than in APOE ε4+ participants (PFDR’s < 0.021;
Figure 5). There were no significant differences in the reliability
of maximum suppression or maximum modulation between the
two APOE subgroups (PFDR’s > 0.27).
DISCUSSION
Test–retest reliability of TMS measures influences their utility as
potential neurophysiologic biomarkers or targets for therapeutic
intervention. As the use of plasticity-inducing rTMS protocols
becomes more common, it is necessary to investigate the
magnitude and sources of their inter- and intra-individual
variability. While some of the factors that contribute to the inter-
individual variability of these types of plasticity metrics among
healthy individuals have been identified (Cheeran et al., 2008,
2009; Antal et al., 2010; Hamada et al., 2013; Goldsworthy et al.,
2014; López-Alonso et al., 2014; Nettekoven et al., 2014, 2015;
Vallence et al., 2015; Suppa et al., 2016; Hordacre et al., 2017;
Jannati et al., 2017), few studies have assessed the intra-individual
reliability of cTBS responses (Vernet et al., 2014; Vallence et al.,
2015) and no study, to our knowledge, has systematically assessed
the test–retest reliability of cTBS aftereffects during 60 min post-
cTBS. The present study was designed to fill this gap by assessing
the test–retest reliability of cTBS aftereffects at 5- or 10-minute
intervals (T5–T60) and of cumulative cTBS aftereffects during
60 min post-cTBS in healthy adults. Furthermore, in order to
provide guidance and reference for future studies, we calculated
adjusted effect sizes that take into account the test–retest
reliability of cTBS measures. Finally, we explored the influences
of age group and common SNPs in BDNF and APOE genes on
the reliability of cTBS aftereffects.
Overall Reliability of Baseline
Neurophysiological Measures
Resting motor threshold had high test–retest reliability (Table 3),
which was comparable with the ICC values reported in most
previous studies (Carroll et al., 2001; Kimiskidis et al., 2004;
Livingston and Ingersoll, 2008; Bastani and Jaberzadeh, 2012;
Ngomo et al., 2012; Hinder et al., 2014; Schambra et al., 2015;
Fried et al., 2017; Davila-Pérez et al., 2018) and somewhat
higher than other studies that found RMT ICCs in the
0.75–0.80 range (Fleming et al., 2012; Liu and Au-Yeung, 2014;
Sankarasubramanian et al., 2015; Hermsen et al., 2016). The
AMT also had high test–retest reliability (Table 3), which was
comparable with the results of previous studies (Ngomo et al.,
2012; Hinder et al., 2014; Fried et al., 2017).
Baseline MEP amplitude had moderate test–retest reliability
(Table 3). The ICC of baseline MEP amplitude found in the
present study (ICC = 0.70) was moderate compared to the wide
range of ICC values for baseline MEP amplitude (–0.16 to 0.87)
reported in previous studies (Kamen, 2004; McDonnell et al.,
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2004; Christie et al., 2007; Fleming et al., 2012; Ngomo et al.,
2012; Hinder et al., 2014; Hermsen et al., 2016; Fried et al.,
2017; Davila-Pérez et al., 2018). Variability of baseline MEP
amplitude was previously found to be associated with variability
of TBS aftereffects (Hordacre et al., 2017; Fried et al., 2017). The
moderate reliability of baseline MEP amplitude in the present
study suggests that such variability was not the main cause of the
low reliability of some of the cTBS measures reported here.
Overall Reliability of cTBS Aftereffects
The finding that differences between the start times of the
two visits influenced the cTBS aftereffects at T10 could be
due to the effect of circadian rhythm on the neuromodulatory
effects of rTMS arising from changes in cortical excitability and
synaptic efficiency during the day (Cohen et al., 2005). While
the present results cannot definitively conclude that circadian
factors influenced the intra-individual variability in plasticity at
T10, future studies could attempt to control for the time of day
or, perhaps even better, to individualize visits to coincide with the
same relative point in each subject’s circadian cycle.
The finding that T5 had one of the lowest between-visit
variabilities among post-cTBS time points is consistent with the
findings of a previous study (Vernet et al., 2014). Importantly,
however, the low between-visit variability of cTBS aftereffects
at T5 and T50 at the group level in the present study did
not translate to high test–retest reliability measures, which take
into account both within-individual and between-individuals
variability; while T50 was the most reliable post-cTBS time point
(ICC = 0.53), T5 had very low reliability (ICC = 0.16). This
pattern of results underlines the importance of calculating the
ICCs of TMS measures rather than relying only on measures of
inter-visit variability at the group level. Further, the low ICCs
at T5 and T10 indicate that the time points expected to show
maximal effects of cTBS (Wischnewski and Schutter, 2015) do
not necessarily exhibit high test–retest reliability. This remained
true for the cumulative measures of cTBS aftereffects over the first
20 min post-cTBS.
The very low test–retest reliability of 1MEPs at T10
(ICC = 0.11) could be due to two factors: (1) The 1MEPs
at T10 in both visits could be the most influenced by BDNF
polymorphism (Jannati et al., 2017). Consistent facilitation of
MEPs, at least numerically, in BDNF Met+ participants in both
visits may have resulted in higher test–retest reliability of T10
1MEP in that subgroup (Figure 5). (2) Despite the relatively long
inter-visit interval in the present study, T10 seemed to exhibit
a metaplastic-like effect similar to those reported with shorter
intervals (Maeda et al., 2000; Gentner et al., 2008; Valero-Cabré
et al., 2008; Oberman et al., 2016) in the overall results (Figure 1),
as well in the Younger group (Figure 2A) and the BDNF Met–
subgroup (Figure 4A). In all three cases, the direction of the
neuromodulatory effect of cTBS at T10 was reversed, at least
numerically, from inhibitory in visit-A to facilitatory in visit-
B. Such reversals, when predominant at the individual level,
would substantially reduce the test–retest reliability of cTBS
aftereffects at T10. Although a previous iTBS study found only
inter-visit intervals shorter than 7 days to be associated with
metaplastic changes after iTBS in aging adults (Fried et al., 2017),
the initial cTBS in the present study may have set into motion
subtle changes that were still present when the second cTBS was
applied. Further, it is possible that demographic, genetic, and
state-dependent factors modulate the metaplastic(-like) effects of
successive TBS sessions (Opie et al., 2017).
The low test–retest reliability of several cTBS aftereffects
resulted in adjustment of large- and medium effect sizes to
medium and small effect sizes, respectively (Table 3). While
calculating the cumulative cTBS measures improved the overall
ICCs over T0–T30 and beyond (Figures 3, 5), the ICCs of the
cumulative measures for the whole sample remained below 0.5.
Attenuation of idealized effect sizes by this level of reproducibility
indicates that detecting significant differences in cTBS responses
between healthy and clinical populations may require sample
sizes that are substantially larger than those used in most previous
cTBS studies (Wischnewski and Schutter, 2015; Chung et al.,
2016; Suppa et al., 2016), unless steps can be implemented to
improve the reliability of this technique.
The finding that within White, non-Hispanic, and right-
handed males (n = 11), none of the 1MEPs at any time
point in either visit differed significantly from zero suggests
that controlling for demographic factors such as gender,
race/ethnicity, and handedness is not enough to overcome the
large inter-individual variability in cTBS responses in either
visit. We found, despite comparable reliability of baseline
neurophysiological measures, T5 and T20–T50 1MEPs were
substantially more reliable in this more-homogenous subgroup,
suggesting that heterogeneity of these demographic factors
influence the reliability of cTBS aftereffects in the whole sample.
While the small sample precludes definitive conclusions about
the effects of gender, handedness, and race/ethnicity, these results
nonetheless appear to suggest that demographic variation plays a
role in the test–retest reliability of cTBS responses.
Age and Reliability of cTBS Aftereffects
The significant Age Group × Visit interaction effect on T10
1MEP indicates that cTBS aftereffects at T10 in the Younger
group, but not in the Older group, switched from inhibitory
in visit-A to facilitatory in visit-B (Figure 2). Such reversal
could be due to metaplasticity or some other state-dependent
factor. The distinct patterns of cTBS aftereffects at T10 among
Younger and Older groups could be due to two factors: (i) Based
on animal studies that have found an age-related reduction in
the efficiency of gamma-aminobutyric acid- (GABA-) mediated
inhibition (Milbrandt et al., 1994; Billard et al., 1995; McQuail
et al., 2012), it is possible that older participants have less-
efficient GABAergic synaptic transmission, which is presumed
to be involved in cTBS-induced plasticity (Stagg et al., 2009;
Trippe et al., 2009). The resulting reduced inhibitory effects of
cTBS, potentially combined with cumulative facilitatory effects of
successive single TMS pulses (Pellicciari et al., 2016), could have
resulted in facilitation of MEPs in the Older group, at least in
visit-A. (ii) The finding that the Younger group, but not the Older
group, showed metaplastic-like changes at T10 could be due to
age-related differences in the priming effect of TBS (Opie et al.,
2017), i.e., a stronger priming effect of cTBS in visit-A among
younger participants.
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FIGURE 4 | Average 1MEPs recorded from the right FDI muscle at 5 to 60 min following cTBS of the left primary motor cortex in two identical visits in the BDNF
Met– (A) and Met+ (B) groups. ∗The 1MEPs in the BDNF Met– group were significantly less than zero at T10 in visit-A (PFDR = 0.042), but not at any other time
point in either visit (p’s > 0.14). The 1MEPs in the BDNF Met+ group were not significantly different from zero at any time point in either visit (PFDR’s > 0.05). Error
bars represent standard error of the mean. BDNF, brain-derived neurotrophic factor; BDNF Met–, Val66Val; BDNF Met+, Val66Met; cTBS, continuous theta-burst
stimulation; FDR, false discovery rate; 1MEP, natural log-transformed, baseline-corrected; MEP amplitude; MEP, motor evoked potential; Met, metionine;
Val, valine.
FIGURE 5 | Test–retest reliability of baseline neurophysiological measures and post-cTBS 1MEP measures separately in the BDNF Met–/Met+ and APOE ε4–/ε4+
groups. AUC of 1MEPs were calculated as the summed products of the average 1MEP across each two consecutive time-points and the time in minutes between
them over T0–T10, T0–15, . . . , T0–T60 intervals (marked by their end time point on the abscissa). The ICC values of RMT, AMT, and baseline MEP amplitude were
not significantly different between the two BDNF groups (p’s > 0.19) or the two APOE groups (p’s > 0.16). Maximum suppression, maximum modulation, and the
AUC of 1MEPs over T0–T30 and beyond were significantly more reliable in the BDNF Met– group than in the BDNF Met+ group (PFDR’s < 0.032). The reliability of
other cumulative 1MEP measures was not significantly different between the two BDNF groups (PFDR > 0.208). All the AUC measures were significantly more
reliable in the APOE ε4– group than in the APOE ε4+ group (PFDR’s < 0.021). The maximum suppression, maximum modulation were not significantly different
between the two APOE groups (PFDR’s > 0.27). AMT, active motor threshold; APOE, apolipoprotein E; APOE ε4+, ε2/ε4 or ε3/ε4 genotype; APOE ε4–, ε2/ε3 or ε3/ε3
genotype; AUC, area under-the-curve; BDNF, brain-derived neurotrophic factor; BDNF Met–, Val66Val; BDNF Met+, Val66Met; cTBS, continuous theta-burst
stimulation; FDR, false discovery rate; ICC, intraclass correlation coefficient; 1MEP, natural log-transformed, baseline-corrected MEP amplitude; MEP, motor evoked
potential; Met, metionine; RMT, resting motor threshold; T0–Tn, over the first n minutes following cTBS; Val, valine.
Similarly, the finding that despite comparable ICCs of baseline
neurophysiological measures in the two age groups, cTBS
aftereffects were substantially less reliable in older participants
(Figure 3) could be due to the age-related decrease in the
efficiency of GABAergic synaptic transmission reported in animal
studies (Milbrandt et al., 1994; Billard et al., 1995; McQuail et al.,
2012). These results indicate that in order to retain adequate
power to detect differences in cTBS measures of plasticity in
future studies, it may be necessary to adjust effect sizes separately
for younger and older age groups.
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BDNF and APOE Polymorphisms and
Reliability of cTBS Aftereffects
Despite comparable ICC values of RMT, AMT, and baseline MEP
amplitude in BDNF Met– and Met+ groups, cTBS aftereffects
at several time points and most cumulative measures of cTBS
aftereffects were substantially more reliable in BDNF Met–
participants than in Met+ participants (Figure 5). This pattern
of results could be due to the following: BDNF Met carrier
status is known to be associated with impaired N-Methyl-D-
aspartic acid- (NMDA-)dependent LTD (Woo et al., 2005),
aberrant GABAergic synaptic transmission (Abidin et al., 2008),
reduced cTBS-induced inhibition of MEPs (Chung et al., 2016),
and “paradoxical” cTBS-induced facilitation of MEPs in visit-
A reported in our previous study (Jannati et al., 2017) and
a few other studies (Gentner et al., 2008; Goldsworthy et al.,
2012; Hellriegel et al., 2012; Brownjohn et al., 2014). The finding
that BDNF Met+ participants showed MEP facilitation, at least
numerically, at T10 in both visits (Figure 4B) supports an
association between BDNF Met+ status and facilitatory response
to cTBS at T10 in the present sample. The noticeably lower test–
retest reliability of cTBS aftereffects in BDNF Met+ participants
(Figure 5) could be due to the less-efficient cTBS-induced
plasticity caused by aberrant GABAergic inhibition (Abidin et al.,
2008), assumed to be involved in the LTD-like effects of cTBS
(Stagg et al., 2009; Trippe et al., 2009).
Despite comparable ICC values of RMT, AMT, and baseline
MEP amplitude in APOE ε4– and ε4+ participants, cTBS
aftereffects at several time points and most cumulative measures
of cTBS aftereffects were substantially more reliable in APOE
ε4– participants than in APOE ε4+ participants (Figure 5).
These results could be due to the influence of APOE ε4 on
NMDA-mediated synaptic plasticity, which has been found to
be involved in TBS aftereffects (Huang et al., 2007; Chen et al.,
2010). These results are also consistent with the less-efficient
rTMS-induced activation of brain networks in APOE ε4 carriers
(Peña-Gomez et al., 2012).
The small number of participants in the BDNF and APOE
subgroups study limits the generalizability of the present findings
on genetic influences on the test–retest reliability of cTBS
measures. Assuming that the noticeable differences in reliability
of cTBS aftereffects in BDNF and APOE subgroups observed
here (Figure 5) are confirmed in future studies, it would be
advantageous to consider the expected proportions of BDNF and
APOE subgroups and adjust effect sizes for each SNP subgroup
accordingly. For example, the minor allele frequencies of rs6265
(BDNF), rs429358 (APOE), and rs7412 (APOE) SNPs in the
admixed American population in the 1000 Genomes Project
(Auton et al., 2015) are 0.1527, 0.1037, and 0.0476, respectively.
As long as that the SNP frequencies among participants do
not significantly deviate from Hardy–Weinberg equilibrium
proportions (Guo and Thompson, 1992; Wigginton et al., 2005),
these frequencies provide good approximations to the frequencies
of minor BDNF and APOE alleles in future cTBS studies.
In comparisons of test–retest reliability of cTBS measures
between age or genetic subgroups, the finding that the subgroups
in each case were comparable in gender, race/ethnicity,
handedness, and the reliability of baseline neurophysiological
measures indicates that differences in heterogeneity of
demographic factors and baseline cortical excitability did
not play a major role in the observed differences in test–retest
reliability of cTBS aftereffects.
In addition to considering age, genetic polymorphisms, inter-
visit interval (Fried et al., 2017), the time of day (Cohen et al.,
2005), and the use of neuronavigation (Julkunen et al., 2009),
other factors that could improve the test–retest reliability of
TMS measures include: ensuring comparable blood glucose levels
and caffeine intake before and during each visit (Specterman
et al., 2005; Cerqueira et al., 2006; Badawy et al., 2013),
comparable amount and quality of sleep the night before each
visit (Civardi et al., 2001; Kreuzer et al., 2011), comparable
intensity and duration of exercise before each visit (Samii
et al., 1997; Lentz and Nielsen, 2002), comparable phase of the
menstrual cycle across visits (Smith et al., 1999; Hattemer et al.,
2007), the use of robotic arms such as the TMS-Robot (Axilum
Robotics, Schiltigheim, France), which can reduce trial-to-trial
variability of MEP amplitude (Foucher et al., 2012), comparable
baseline MEP amplitude across plasticity visits (Fried et al.,
2017), and implementing closed-loop systems that trigger TMS
pulses timed to real-time, EEG-defined indices of brain states
(Zrenner et al., 2016, 2018).
CONCLUSION
The present study assessed the test–retest reliability of cTBS
aftereffects in healthy adults. cTBS aftereffects at most individual
time points had low to moderate reliability. Cumulative cTBS
measures over the first 30 min and beyond were relatively more
reliable. Effect sizes adjusted for reliability of cTBS aftereffects
are provided to help future studies retain adequate power for
comparing M1 cTBS responses between healthy and clinical
populations. Those calculations resulted in adjustment of several
large and medium effect sizes to medium and small effect sizes,
respectively, thereby substantially increasing the estimates of the
required sample size to detect a significant difference in cTBS
responses between healthy and clinical populations. Exploratory
analyses found cTBS aftereffects were substantially more reliable
in younger participants (age < 35 years) and those with BDNF
Met– and APOE ε4– genotypes.
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